Pharmacy Times
JULY 8, 2022
David Pope, PharmD, CDE, the EVP of Innovation and Industry Relations at OmniSYS, discusses the FDA’s announcement updating pharmacists’ prescriptive authority for the COVID-19 antiviral Paxlovid.
pharmaphorum
JULY 8, 2022
The pharmaceutical industry is increasingly relying on artificial intelligence to power its drug discovery and development efforts, and its spend in this area has created a multibillion-dollar market for AI technologies. That’s the conclusion of a GlobalData report , which notes that AI is being used to enhance computer-aided drug design (CADD) in a bid to reduce the time and costs involved in getting a new drug to market.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JULY 8, 2022
Hypervitaminosis D, a condition characterized by elevated vitamin D levels, is associated with potential serious health issues, such as psychosis, abdominal pain, vomiting, pancreatitis, and renal failure.
European Pharmaceutical Review
JULY 8, 2022
As established facilities age, various risk considerations emerge. While some may continue to function effectively without any additional considerations, many will require additional checks and assessment. In an article published in the Journal of Validation Technology (JVT), pharmaceutical microbiologist and contamination control expert Tim Sandle identified ten categories of risk presented by aging.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JULY 8, 2022
ProAir Digihaler Inhalation Powder is indicated for the treatment or prevention of bronchospasm in those with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.
Pharmaceutical Technology
JULY 8, 2022
Specialised Therapeutics’ oral drug, Nerlynx (neratinib) has obtained the Philippines Food and Drug Administration approval to lower the recurrence or mortality risk in early-stage HER2-positive (HER2+) breast cancer patients. The treatment is indicated as extended adjuvant treatment for adults with early-stage HER2-overexpressed/amplified breast cancer following adjuvant trastuzumab-based therapy.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
pharmaphorum
JULY 8, 2022
The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial space. Hybrid or decentralised clinical trials (DCTs) have gained traction as technology, infrastructure and knowledge have evolved to support their use. Preliminary research suggests that hybrid DCTs can reduce trial timing and resources , improve patient-centricity and patient engagement , and expand access and recruitment and increase diversity , mitigate bias, and re
Pharmacy Times
JULY 8, 2022
Autologous stem cell transplantation was underutilized in community settings for mantle cell lymphoma.
PharmExec
JULY 8, 2022
Dealing with discrimination and bias throughout her career, Otsuka Pharmaceutical’s Christine Sakdalan has forged a strong leadership path built around a two-pronged mission—finding true meaning in the patient journey through market research and data analytics, and mentoring and supporting the development of today’s aspiring professionals.
Pharmacy Times
JULY 8, 2022
Simple changes to each day can improve motivation and wellness for pharmacists.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
PharmExec
JULY 8, 2022
COVID-19 pandemic, the challenging capital-markets climate in biotech, and a more innovative and specialty treatment focus has increased reliance on the finance arm as a key strategic cog.
Pharmacy Times
JULY 8, 2022
Christopher Fine, MD, FACC, a cardiologist at National Jewish Health, discusses the relationship between heart disease and cancer and the importance of the field of cardio-oncology when treating patients with cancer.
Pharmaceutical Technology
JULY 8, 2022
Swedish Orphan Biovitrum AB (Sobi) has signed an exclusive licence agreement with ADC Therapeutics to develop and market Zynlonta (loncastuximab tesirine) for hematologic and solid tumour indications in Europe and mostinternational markets, for up to $435m. The deal, however, excludes the US, Greater China, Singapore and Japan. Zynlonta is a CD19-directed antibody-drug conjugate (ADC).
Pharmacy Times
JULY 8, 2022
Tildrakizumab-asmn (Ilumya) is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmaceutical Commerce
JULY 8, 2022
How did the industry get here and what alternatives can be sought out?
Pharmacy Times
JULY 8, 2022
In February of this year, the new statistics came out where we're at now 37 million with diabetes and 96 million with prediabetes.
PharmExec
JULY 8, 2022
Continent has shed its ‘emerging’ status on world biopharma stage.
Pharmacy Times
JULY 8, 2022
Christine Walko, PharmD, BCOP, FCCP, discusses some new developments for PARP inhibitors in cancer care for patients with homologous recombination deficiency.
Pharmaceutical Technology
JULY 8, 2022
Over recent years, bispecific T-cell engagers (BiTEs) have attracted significant attention for their potential in treating a plethora of haematological and solid tumours by enhancing the anti-tumour responses of endogenous T-cells. BiTEs are a relatively nascent modality and have yet to benefit from the identification of robust biomarkers and novel combination approaches, such as in combination with anti-CD20 therapies, with the view to attenuate malignant B-cell survival and enhance clinical re
Pharmacy Times
JULY 8, 2022
The Pharmacist Patient Care Process provides really consistent language for pharmacists and pharmacy team members to talk about what teams are already doing.
Pharmaceutical Technology
JULY 8, 2022
Europe was the fastest growing region for cloud hiring among pharmaceutical industry companies in the three months ending April. The number of roles in Europe made up 16.2% of total cloud jobs - up from 13.6% in the same quarter last year. That was followed by North America, which saw a 0.3 year-on-year percentage point change in cloud roles. The figures are compiled by GlobalData, who track the number of new job postings from key companies in various sectors over time.
PharmExec
JULY 8, 2022
A proactive and tailored compliance department—with the nimbleness to adapt strategies on the fly—is a critical shield for life sciences companies during government investigations.
Pharmaceutical Technology
JULY 8, 2022
Digitalization related jobs that were closed during Q1 2022 had been online for an average of 34 days when they were taken offline. This was an increase compared to the equivalent figure a year earlier, indicating that the required skillset for these roles has become harder to find in the past year. Digitalization is one of the topics that GlobalData, our parent company and from whom the data for this article is taken, have identified as being a key disruptive technology force facing companies i
Board Vitals - Pharmacist
JULY 8, 2022
Failure is a part of life, even in healthcare. While mistakes will inevitably happen, we must learn from these errors in order to have a greater chance of success in the future. As part of a commitment to supporting the doctors of the future, BoardVitals awarded its third annual Medical School Scholarship to three winners. For the 2022 BoardVitals Medical School Scholarship , we asked current medical students to answer the question: “What have you learned from previous failures and how have thes
Pharmaceutical Technology
JULY 8, 2022
Xenetic Biosciences and Catalent Pharma Solutions have signed an agreement for the cGMP manufacturing of the Xenetic’s recombinant protein, Human DNase I. Under the deal, Catalent will use its biomanufacturing capabilities in Madison, Wisconsin to advance Xenetic’s DNase clinical development programme and progress it to first-in-human studies. The interventional DNase based oncology platform of Xenetic is intended to boost outcomes of current therapies, including immunotherapies.
PharmD Live
JULY 8, 2022
Burnout can keep the best from wanting to open the doctor’s office each day. A national survey, The Physician Task Load and the Risk of Burnout Among US Physicians ( The Joint Commission Journal on Quality and Patient Safety 2021; 47:76–85 ), describes the look and feel of an albatross around the necks of struggling providers. The metaphor is supported by the direct relationship between physician task load and burnout.
NICE
JULY 8, 2022
The course is made up of six learning modules and can be found on the EHDEN Academy website. The EHDEN Academy is a free learning resource, focusing on providing the knowledge, skills, and tools to access and use real-world evidence. Innovative medical technologies and devices are increasingly important in delivering positive health outcomes and driving health efficiencies.
The Luxe Pharmacist
JULY 8, 2022
I am a huge sucker for a sale, especially when it’s at one of my favorite stores! I mean why buy boots two months from now when you can buy them this week for like $70 less right?! I’m linking all my favorite sales pics here and will be uploading more on my LTK so be sure to follow me there!
PharmExec
JULY 8, 2022
Pharma companies should review their commission-based compensation arrangements with independent contractors to address enforcement risk under the Anti-Kickback Statute, in light of recent Department of Justice enforcement.
Pharmaceutical Technology
JULY 8, 2022
In the first half of 2022 the number of deals relating to regenerative medicine decreased significantly by 40% from the same period in 2021. This marks a deceleration in growth from the 27.6% decrease in deals that occurred in H2 2021 relative to the same period a year earlier. GlobalData's deals database looks at mergers, acquisitions and venture capital and private equity investments taking place daily between thousands of companies across the world.
pharmaphorum
JULY 8, 2022
Swedish rare disease specialist Sobi is paying $55 million upfront to license rights to ADC Therapeutics’ lymphoma therapy Zynlonta – approved in the US last year – in Europe and other international markets. The deal expands Sobi’s position in orphan diseases within haematology, one of its core focus areas, and also includes a $50 million payment Zynlonta (loncastuximab tesirine) is approved in the EU and another $330 million in milestone payments tied to other regulatory and sales o
Pharmaceutical Commerce
JULY 8, 2022
Willis Chandler, AmerisourceBergen’s recently named President of Biopharma Services, Strategic Global Sourcing and Commercial Solutions, talks about the new investments AB is making to build out its capabilities and its new cell and gene therapy service line.
pharmaphorum
JULY 8, 2022
PharmStars , the pharma-focused accelerator for digital health startups, is pleased to announce that it is now accepting applications for its Fall 2022 cohort with the theme, “Innovations in Real-World Evidence.”. Data gathered from wearables, mobile devices, and other digital tools can yield reliable, usable clinical and health-related information as well as evidence.
PharmExec
JULY 8, 2022
With heightened government scrutiny on educational forums, biopharma manufacturers need a sound framework that demonstrates they are following best practices.
Expert insights. Personalized for you.
132 
Let's personalize your content